1. Home
  2. ATEC vs ADPT Comparison

ATEC vs ADPT Comparison

Compare ATEC & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEC
  • ADPT
  • Stock Information
  • Founded
  • ATEC 1990
  • ADPT 2009
  • Country
  • ATEC United States
  • ADPT United States
  • Employees
  • ATEC N/A
  • ADPT N/A
  • Industry
  • ATEC Medical/Dental Instruments
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATEC Health Care
  • ADPT Health Care
  • Exchange
  • ATEC Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • ATEC 1.3B
  • ADPT 1.2B
  • IPO Year
  • ATEC 2006
  • ADPT 2019
  • Fundamental
  • Price
  • ATEC $10.61
  • ADPT $8.27
  • Analyst Decision
  • ATEC Strong Buy
  • ADPT Buy
  • Analyst Count
  • ATEC 10
  • ADPT 5
  • Target Price
  • ATEC $17.50
  • ADPT $9.10
  • AVG Volume (30 Days)
  • ATEC 1.4M
  • ADPT 1.5M
  • Earning Date
  • ATEC 02-26-2025
  • ADPT 02-11-2025
  • Dividend Yield
  • ATEC N/A
  • ADPT N/A
  • EPS Growth
  • ATEC N/A
  • ADPT N/A
  • EPS
  • ATEC N/A
  • ADPT N/A
  • Revenue
  • ATEC $572,739,000.00
  • ADPT $178,957,000.00
  • Revenue This Year
  • ATEC $28.51
  • ADPT $20.67
  • Revenue Next Year
  • ATEC $20.37
  • ADPT $21.79
  • P/E Ratio
  • ATEC N/A
  • ADPT N/A
  • Revenue Growth
  • ATEC 27.21
  • ADPT 5.10
  • 52 Week Low
  • ATEC $4.88
  • ADPT $2.28
  • 52 Week High
  • ATEC $15.69
  • ADPT $8.95
  • Technical
  • Relative Strength Index (RSI)
  • ATEC 45.32
  • ADPT 58.94
  • Support Level
  • ATEC $10.66
  • ADPT $8.09
  • Resistance Level
  • ATEC $11.17
  • ADPT $8.69
  • Average True Range (ATR)
  • ATEC 0.42
  • ADPT 0.64
  • MACD
  • ATEC -0.15
  • ADPT -0.00
  • Stochastic Oscillator
  • ATEC 9.44
  • ADPT 65.66

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: